ResearcherNanjing University of Chinese MedicineNo recent work listed

Changliang Xu

ORCID-verified (high confidence)As of 13 November 2026

Matched on ORCID iD 0000-0002-1428-7220; OpenAlex author ID A5100691009.

Their work

Counts cover pancreatic cancer work only: a researcher’s other papers, trials and grants are not in these records.

Pancreatic cancer papers: 1 (first author 0, last author 1)
Pancreatic cancer trials: 0
Pancreatic cancer grants: 0
Collaborators: 1

Papers, trials and grants by year

2015: 1 paper

Papers 1

Longikaurin E induces apoptosis of pancreatic cancer cells via modulation of the p38 and PI3K/AKT pathways by ROS. Last author DOI 10.1007/s00210-015-1107-4 ↗

Closest collaborators

The 1 strongest of 1 ranked by shared papers, trials and grants, with recent and small-team work weighing most.

Haibo Cheng · 1 shared paper, 2015
- Paper Longikaurin E induces apoptosis of pancreatic cancer cells via modulation of the p38 and PI3K/AKT pathways by ROS. DOI 10.1007/s00210-015-1107-4 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (the fewest links first, then the links with the most shared work). Built from public records only; no contact details are kept.